Skip to main content

Advertisement

Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Comparison of in-hospital glycemic variability and admission blood glucose in predicting short-term outcomes in non-diabetes patients with ST elevation myocardial infarction underwent percutaneous coronary intervention

Fig. 1

a Incidence of MACE after 3-month follow-up in relation to MAGE levels (white bars MAGE level ≤3.26 mmol/L; black bars MAGE level >3.26 mmol/L). b Incidence of MACE after 3-month follow-up in relation to ABG levels (white bars ABG level ≤7.80 mmol/L; black bars ABG level >7.80 mmol/L)

Back to article page